NYSE:PFE - New York Stock Exchange, Inc. - US7170811035 - Common Stock - Currency: USD
Taking everything into account, PFE scores 6 out of 10 in our fundamental rating. PFE was compared to 198 industry peers in the Pharmaceuticals industry. PFE has an excellent profitability rating, but there are some minor concerns on its financial health. A decent growth rate in combination with a cheap valuation! Better keep an eye on PFE. Finally PFE also has an excellent dividend rating.
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | 3.79% | ||
ROE | 8.73% | ||
ROIC | 7.77% |
Industry Rank | Sector Rank | ||
---|---|---|---|
OM | 27.12% | ||
PM (TTM) | 12.62% | ||
GM | 74.57% |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | 0.65 | ||
Debt/FCF | 5.54 | ||
Altman-Z | 2.09 |
Industry Rank | Sector Rank | ||
---|---|---|---|
Current Ratio | 1.26 | ||
Quick Ratio | 0.96 |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | 7.33 | ||
Fwd PE | 7.46 |
Industry Rank | Sector Rank | ||
---|---|---|---|
P/FCF | 11.89 | ||
EV/EBITDA | 6.65 |
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | 7.61% |
23.52
+0.52 (+2.26%)
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | 7.61% |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | 7.33 | ||
Fwd PE | 7.46 | ||
P/S | 2.14 | ||
P/FCF | 11.89 | ||
P/OCF | 9.54 | ||
P/B | 1.48 | ||
P/tB | N/A | ||
EV/EBITDA | 6.65 |
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | 3.79% | ||
ROE | 8.73% | ||
ROCE | 9.87% | ||
ROIC | 7.77% | ||
ROICexc | 8.64% | ||
ROICexgc | 41.11% | ||
OM | 27.12% | ||
PM (TTM) | 12.62% | ||
GM | 74.57% | ||
FCFM | 17.96% |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | 0.65 | ||
Debt/FCF | 5.54 | ||
Debt/EBITDA | 2.45 | ||
Cap/Depr | 40.16% | ||
Cap/Sales | 4.43% | ||
Interest Coverage | 5.35 | ||
Cash Conversion | 58.69% | ||
Profit Quality | 142.33% | ||
Current Ratio | 1.26 | ||
Quick Ratio | 0.96 | ||
Altman-Z | 2.09 |